Ibrutinib-induced rapid response in chemotherapy-refractory Richter's Syndrome

被引:0
|
作者
Fischer-Maranta, A. [1 ]
Bastian, S. [1 ]
Mey, U. [1 ]
Cogliatti, S. [2 ]
Hohloch, K. [1 ,3 ]
机构
[1] Kantonspital Graubunden, Hamatol & Onkol, Chur, Switzerland
[2] Kantonspital St Gallen, Inst Pathol, St Gallen, Switzerland
[3] Uniklin Goettingen, Hamatol Onkol, Gottingen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P534
引用
收藏
页码:157 / 157
页数:1
相关论文
共 50 条
  • [21] Utilizing Clinical Features of Progression to Predict Richter's Syndrome in Patients with CLL Progressing after Ibrutinib
    Kittai, Adam S.
    Huang, Ying
    Keiter, Ashleigh
    Beckwith, Kyle A.
    Goldstein, Daniel
    Bhat, Seema A.
    Bond, David A.
    Byrd, John C.
    Grever, Michael R.
    Rogers, Kerry A.
    Woyach, Jennifer A.
    BLOOD, 2021, 138 : 3731 - +
  • [22] Phase II trial of gemcitabine in patients (pts) with relapsed or chemotherapy-refractory Hodgkin's lymphoma (HL).
    Venkatesh, H
    Di Bella, NJ
    Cuasay, LC
    Vellek, M
    Mirabel, M
    Asmar, L
    BLOOD, 2002, 100 (11) : 300B - 300B
  • [23] Effect of preoperative concomitant chemoradiotherapy in chemotherapy-refractory breast cancer on feasibility of curative surgery and pathologic tumor response
    Ghorbel, I.
    Heymann, S.
    Delaloge, S.
    Belaid, A.
    Azoury, F.
    Mazouni, C.
    Balleyguier, C.
    Vielh, P.
    Marsiglia, H.
    Bourgier, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Addition of Rituximab Abrogates Ibrutinib-Induced Lymphocytosis and Promotes More Rapid Decrease in Absolute Lymphocyte Counts in Patients with Relapsed Chronic Lymphocytic Leukemia
    Kim, Ekaterina
    Werner, Lillian
    Keating, Michael J.
    Wierda, William G.
    Ferrajoli, Alessandra
    Estrov, Zeev
    Zacharian, Gracy
    Kipps, Thomas J.
    Kantarjian, Hagop M.
    Neuberg, Donna
    O'Brien, Susan
    Burger, Jan A.
    BLOOD, 2014, 124 (21)
  • [25] IBRUTINIB EFFICACY AGAINST RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN A PATIENT WITH PROLONGED REMISSION OF RICHTER'S SYNDROME
    Albi, E.
    Baldoni, S.
    Aureli, P.
    Dorillo, E.
    Del Papa, B.
    Ascani, S.
    Di Ianni, M.
    Falzetti, F.
    Sportoletti, P.
    HAEMATOLOGICA, 2017, 102 : 157 - 157
  • [26] Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib
    Wang, Hanyin
    Tian, Shulan
    Zhao, Qing
    Blumenschein, Wendy
    Yearley, Jennifer H.
    Secreto, Charla R.
    Sinha, Sutapa
    Call, Timothy G.
    Wang, Yucai
    Parikh, Sameer A.
    Kenderian, Saad S.
    He, Rong
    Leis, Jose F.
    Shi, Min
    Kay, Neil E.
    Slager, Susan L.
    Braggio, Esteban
    Yan, Huihuang
    Ding, Wei
    BLOOD, 2020, 136
  • [27] Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden
    Gbolahan, Olumide
    Hashemi-Sadraei, Neda
    O'Neil, Bert
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06): : 644 - 648
  • [28] EBV-positive Richter's syndrome with laboratory features of Burkitt's lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia
    Hussaini, Mohammad O.
    Rehman, Alman
    Chavez, Julio C.
    Pinilla-Ibarz, Javier
    Horna, Pedro
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1753 - 1756
  • [29] Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review
    Yoshitomi, Yutaro
    Kawashima, Akira
    Nakayama, Hidetsugu
    Nakamoto, Takato
    Ando, Naokatsu
    Uemura, Haruka
    Mizushima, Daisuke
    Aoki, Takahiro
    Tanuma, Junko
    Teruya, Katsuji
    Gatanaga, Hiroyuki
    Watanabe, Koji
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (10) : 1061 - 1064
  • [30] Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement
    Chan, Kah-Lok
    van der Weyden, Carrie
    Khoo, Christine
    Lade, Stephen
    Blombery, Piers
    Westerman, David
    Khot, Amit
    Melo, Brian
    Johnstone, Ricky W.
    Prince, H. Miles
    Dickinson, Michael
    LEUKEMIA & LYMPHOMA, 2017, 58 (04) : 996 - 998